Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for DAWN

Stock Name	Day One Biopharmaceuticals Inc
Ticker	DAWN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US23954D1090

Show aggregate DAWN holdings

News associated with DAWN

Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month Low Following Analyst Downgrade: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday after Needham & Company LLC lowered their price target on the stock from $18.00 to $16.00. Needham & Company LLC currently has a buy rating on the stock. Day One Biopharmaceuticals traded as low […] - 2025-08-07 02:46:44
Allianz Asset Management GmbH Buys Shares of 25,000 Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Allianz Asset Management GmbH bought a new stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm bought 25,000 shares of the company’s stock, valued at approximately $198,000. A number of other hedge funds have also made changes to their positions in DAWN. Wealth Enhancement […] - 2025-08-05 04:26:54
Arizona State Retirement System Reduces Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Arizona State Retirement System lessened its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 8.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,902 shares of the company’s stock after selling 1,471 shares during the quarter. Arizona State Retirement […] - 2025-07-24 04:38:49
Alps Advisors Inc. Lowers Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Alps Advisors Inc. lowered its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 10.1% during the first quarter, HoldingsChannel.com reports. The firm owned 73,343 shares of the company’s stock after selling 8,206 shares during the period. Alps Advisors Inc.’s holdings in Day One Biopharmaceuticals were worth $582,000 at the end […] - 2025-07-15 06:25:18
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives $29.00 Average Price Target from Brokerages: Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given a consensus rating of “Buy” by the seven analysts that are covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […] - 2025-07-14 02:56:48
Analysts Set Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Price Target at $30.57: Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given a consensus recommendation of “Buy” by the eight analysts that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 […] - 2025-06-19 02:46:56
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 15.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 75,579 shares of the company’s stock after buying […] - 2025-06-11 05:14:48
Two Sigma Investments LP Lowers Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Two Sigma Investments LP lessened its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 33.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 271,776 shares of the company’s stock after selling 135,725 shares during the quarter. Two Sigma […] - 2025-05-30 04:51:01
Deutsche Bank AG Buys 35,460 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Deutsche Bank AG raised its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 358,920 shares of the company’s stock after buying an additional 35,460 shares during the […] - 2025-05-20 05:12:56
Mariner LLC Sells 10,376 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Mariner LLC lessened its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 47.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 11,669 shares of the company’s stock after selling 10,376 shares during the period. Mariner LLC’s holdings in Day One Biopharmaceuticals were worth $148,000 as of its most recent filing with […] - 2025-05-08 04:40:46
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up Following Earnings Beat: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $6.99, but opened at $7.52. Day One Biopharmaceuticals shares last traded at $6.64, with a volume of 935,489 shares trading hands. The company reported ($0.35) earnings […] - 2025-05-08 03:12:49
Hsbc Holdings PLC Makes New Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Hsbc Holdings PLC acquired a new position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 38,583 shares of the company’s stock, valued at approximately $481,000. Several other hedge funds also […] - 2025-05-07 04:56:57
Wells Fargo & Company MN Sells 4,744 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Wells Fargo & Company MN cut its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 8.4% during the 4th quarter, Holdings Channel reports. The firm owned 51,735 shares of the company’s stock after selling 4,744 shares during the period. Wells Fargo & Company MN’s holdings in Day One Biopharmaceuticals were […] - 2025-05-02 04:24:48
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives $32.29 Average Target Price from Analysts: Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are currently covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-04-30 02:34:47
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Acquired by Fmr LLC: Fmr LLC increased its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 73.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,887,467 shares of the company’s stock after purchasing an additional 5,475,087 shares […] - 2025-04-14 05:15:07
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Corebridge Financial Inc.: Corebridge Financial Inc. reduced its stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,805 shares of the company’s stock after selling 1,948 shares during the quarter. Corebridge Financial Inc.’s holdings in Day […] - 2025-04-11 05:40:56
Wellington Management Group LLP Grows Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Wellington Management Group LLP raised its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 731,303 shares of the company’s stock after purchasing an additional 9,722 shares during the quarter. Wellington Management […] - 2025-04-10 06:06:51
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Cut to $27.00 by Analysts at The Goldman Sachs Group: Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price objective trimmed by The Goldman Sachs Group from $39.00 to $27.00 in a research note published on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also issued reports on DAWN. JPMorgan Chase & Co. dropped their […] - 2025-03-26 04:38:43
Charles Schwab Investment Management Inc. Raises Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Charles Schwab Investment Management Inc. boosted its holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 5.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 535,501 shares of the company’s stock after buying an additional 28,053 shares during the period. Charles Schwab Investment Management Inc.’s […] - 2025-03-25 05:13:03
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Lowered to $34.00 at JPMorgan Chase & Co.: Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report) had its target price dropped by JPMorgan Chase & Co. from $39.00 to $34.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 273.63% from the company’s current […] - 2025-03-07 04:50:44
Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 1-Year Low Following Weak Earnings: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) hit a new 52-week low on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $10.06 and last traded at $10.54, with a volume of 436845 shares. The stock had previously closed at $11.82. The company reported ($0.69) earnings […] - 2025-02-27 07:08:59
Day One Biopharmaceuticals (NASDAQ:DAWN) Given New $43.00 Price Target at The Goldman Sachs Group: Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) had its price objective decreased by The Goldman Sachs Group from $48.00 to $43.00 in a research note released on Monday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. Several other analysts have also issued reports on DAWN. Needham & Company LLC […] - 2025-02-11 06:28:49

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc DAWN holdings

Date	Number of DAWN Shares Held	Base Market Value of DAWN Shares	Local Market Value of DAWN Shares	Change in DAWN Shares Held	Change in DAWN Base Value	Current Price per DAWN Share Held	Previous Price per DAWN Share Held
2025-09-26 (Friday)	13,064	USD 88,443	USD 88,443
2025-09-25 (Thursday)	13,064	USD 87,268	USD 87,268	0	USD -2,482	USD 6.68004	USD 6.87002
2025-09-24 (Wednesday)	13,064	USD 89,750	USD 89,750
2025-09-17 (Wednesday)	12,980	USD 90,730	USD 90,730	0	USD -1,558	USD 6.98998	USD 7.11002
2025-09-16 (Tuesday)	12,980	USD 92,288	USD 92,288
2025-09-12 (Friday)	12,896	USD 91,820	USD 91,820
2025-09-11 (Thursday)	12,896	USD 95,044	USD 95,044	168	USD -34	USD 7.37004	USD 7.46999

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DAWN by Blackrock for IE00B3VWM098

Show aggregate share trades of DAWN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 168 7.370* 9.39
2025-08-21 SELL -42 6.980* 9.41 Profit of 395 on sale
2025-07-31 BUY 126 6.710* 9.44
2025-06-30 SELL -84 6.500* 9.79 Profit of 822 on sale
2025-06-25 SELL -42 6.440* 9.86 Profit of 414 on sale
2025-06-20 SELL -84 6.320* 9.93 Profit of 834 on sale
2025-05-23 BUY 42 6.270* 10.47
2025-05-19 SELL -42 6.480* 10.61 Profit of 446 on sale
2025-05-15 SELL -126 6.160* 10.69 Profit of 1,346 on sale
2025-05-12 SELL -42 6.580* 10.80 Profit of 454 on sale
2025-05-09 SELL -42 6.450* 10.84 Profit of 455 on sale
2025-04-30 SELL -42 7.780* 11.08 Profit of 465 on sale
2025-04-24 SELL -84 7.900* 11.21 Profit of 942 on sale
2025-04-17 SELL -42 6.840* 11.43 Profit of 480 on sale
2025-04-15 SELL -126 7.190* 11.52 Profit of 1,452 on sale
2025-04-14 SELL -126 7.220* 11.57 Profit of 1,458 on sale
2025-04-09 SELL -168 7.270* 11.72 Profit of 1,970 on sale
2025-04-07 SELL -294 7.020* 11.84 Profit of 3,480 on sale
2025-04-04 SELL -420 7.220* 11.89 Profit of 4,994 on sale
2025-03-31 BUY 42 7.930* 12.04
2025-03-19 SELL -84 8.280* 12.44 Profit of 1,045 on sale
2025-03-14 SELL -252 8.120* 12.61 Profit of 3,179 on sale
2025-03-13 SELL -84 8.700* 12.67 Profit of 1,064 on sale
2025-03-12 SELL -1,428 8.790* 12.72 Profit of 18,171 on sale
2025-03-07 SELL -84 8.670* 12.92 Profit of 1,085 on sale
2025-03-06 SELL -126 9.100* 12.97 Profit of 1,635 on sale
2025-03-03 SELL -42 8.250* 13.17 Profit of 553 on sale
2025-02-28 SELL -252 9.060* 13.24 Profit of 3,335 on sale
2025-02-26 SELL -42 9.870* 13.36 Profit of 561 on sale
2025-02-25 SELL -126 11.820* 13.38 Profit of 1,686 on sale
2025-02-18 BUY 210 11.930* 13.53
2025-02-13 BUY 42 12.210* 13.61
2025-02-12 BUY 42 12.130* 13.64
2025-02-11 BUY 126 11.920* 13.68
2025-02-06 BUY 378 12.510* 13.78
2025-01-27 BUY 42 12.770* 14.04
2024-12-30 BUY 210 12.580* 14.22
2024-12-06 BUY 168 13.750* 14.30
2024-12-05 BUY 42 13.460* 14.32
2024-12-04 BUY 210 13.800* 14.34
2024-11-29 BUY 210 13.930* 14.41
2024-11-27 BUY 168 13.720* 14.47
2024-11-26 BUY 42 13.540* 14.51
2024-11-21 BUY 210 13.340* 14.67
2024-11-20 BUY 126 13.620* 14.73
2024-11-18 BUY 504 13.010* 14.91
2024-11-12 BUY 336 15.640* 14.87
2024-11-08 BUY 210 16.390* 14.76
2024-11-07 BUY 630 15.760* 14.68
2024-11-06 BUY 84 15.430* 14.62
2024-10-31 BUY 42 14.720* 14.51
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	168	7.370*	9.39
2025-08-21	SELL	-42	6.980*	9.41 Profit of 395 on sale
2025-07-31	BUY	126	6.710*	9.44
2025-06-30	SELL	-84	6.500*	9.79 Profit of 822 on sale
2025-06-25	SELL	-42	6.440*	9.86 Profit of 414 on sale
2025-06-20	SELL	-84	6.320*	9.93 Profit of 834 on sale
2025-05-23	BUY	42	6.270*	10.47
2025-05-19	SELL	-42	6.480*	10.61 Profit of 446 on sale
2025-05-15	SELL	-126	6.160*	10.69 Profit of 1,346 on sale
2025-05-12	SELL	-42	6.580*	10.80 Profit of 454 on sale
2025-05-09	SELL	-42	6.450*	10.84 Profit of 455 on sale
2025-04-30	SELL	-42	7.780*	11.08 Profit of 465 on sale
2025-04-24	SELL	-84	7.900*	11.21 Profit of 942 on sale
2025-04-17	SELL	-42	6.840*	11.43 Profit of 480 on sale
2025-04-15	SELL	-126	7.190*	11.52 Profit of 1,452 on sale
2025-04-14	SELL	-126	7.220*	11.57 Profit of 1,458 on sale
2025-04-09	SELL	-168	7.270*	11.72 Profit of 1,970 on sale
2025-04-07	SELL	-294	7.020*	11.84 Profit of 3,480 on sale
2025-04-04	SELL	-420	7.220*	11.89 Profit of 4,994 on sale
2025-03-31	BUY	42	7.930*	12.04
2025-03-19	SELL	-84	8.280*	12.44 Profit of 1,045 on sale
2025-03-14	SELL	-252	8.120*	12.61 Profit of 3,179 on sale
2025-03-13	SELL	-84	8.700*	12.67 Profit of 1,064 on sale
2025-03-12	SELL	-1,428	8.790*	12.72 Profit of 18,171 on sale
2025-03-07	SELL	-84	8.670*	12.92 Profit of 1,085 on sale
2025-03-06	SELL	-126	9.100*	12.97 Profit of 1,635 on sale
2025-03-03	SELL	-42	8.250*	13.17 Profit of 553 on sale
2025-02-28	SELL	-252	9.060*	13.24 Profit of 3,335 on sale
2025-02-26	SELL	-42	9.870*	13.36 Profit of 561 on sale
2025-02-25	SELL	-126	11.820*	13.38 Profit of 1,686 on sale
2025-02-18	BUY	210	11.930*	13.53
2025-02-13	BUY	42	12.210*	13.61
2025-02-12	BUY	42	12.130*	13.64
2025-02-11	BUY	126	11.920*	13.68
2025-02-06	BUY	378	12.510*	13.78
2025-01-27	BUY	42	12.770*	14.04
2024-12-30	BUY	210	12.580*	14.22
2024-12-06	BUY	168	13.750*	14.30
2024-12-05	BUY	42	13.460*	14.32
2024-12-04	BUY	210	13.800*	14.34
2024-11-29	BUY	210	13.930*	14.41
2024-11-27	BUY	168	13.720*	14.47
2024-11-26	BUY	42	13.540*	14.51
2024-11-21	BUY	210	13.340*	14.67
2024-11-20	BUY	126	13.620*	14.73
2024-11-18	BUY	504	13.010*	14.91
2024-11-12	BUY	336	15.640*	14.87
2024-11-08	BUY	210	16.390*	14.76
2024-11-07	BUY	630	15.760*	14.68
2024-11-06	BUY	84	15.430*	14.62
2024-10-31	BUY	42	14.720*	14.51

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DAWN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	101,088	200	226,936	44.5%
2025-09-18	103,556	0	310,496	33.4%
2025-09-17	103,072	0	365,044	28.2%
2025-09-16	79,162	0	291,001	27.2%
2025-09-15	69,316	0	266,554	26.0%
2025-09-12	86,716	0	211,871	40.9%
2025-09-11	128,932	0	293,676	43.9%
2025-09-10	79,314	0	382,087	20.8%
2025-09-09	55,409	0	163,764	33.8%
2025-09-08	90,649	0	294,167	30.8%
2025-09-05	105,307	1,514	322,531	32.7%
2025-09-04	97,409	30,755	230,334	42.3%
2025-09-03	149,459	0	598,859	25.0%
2025-09-02	131,041	0	357,911	36.6%
2025-08-29	103,006	0	253,079	40.7%
2025-08-28	142,808	0	342,964	41.6%
2025-08-27	279,733	0	495,581	56.4%
2025-08-26	244,371	0	437,852	55.8%
2025-08-25	164,743	0	326,391	50.5%
2025-08-22	185,892	574	527,339	35.3%
2025-08-21	133,004	0	203,717	65.3%
2025-08-20	160,089	0	295,172	54.2%
2025-08-19	295,070	1,302	645,893	45.7%
2025-08-18	173,726	6	669,912	25.9%
2025-08-15	246,981	16	565,738	43.7%
2025-08-14	158,753	0	313,521	50.6%
2025-08-13	261,892	310	805,120	32.5%
2025-08-12	1,015,402	2,800	1,643,569	61.8%
2025-08-11	162,783	117	830,079	19.6%
2025-08-08	365,158	97	619,822	58.9%
2025-08-07	745,066	10,488	1,183,692	62.9%
2025-08-06	2,444,048	246,093	4,453,515	54.9%
2025-08-05	812,742	1,386	2,254,659	36.0%
2025-08-04	231,567	0	1,401,581	16.5%
2025-08-01	226,722	0	332,728	68.1%
2025-07-31	325,107	72	411,822	78.9%
2025-07-30	190,593	0	263,030	72.5%
2025-07-29	244,709	6,529	435,055	56.2%
2025-07-28	378,434	0	572,957	66.0%
2025-07-25	327,639	298	629,602	52.0%
2025-07-24	297,043	0	756,302	39.3%
2025-07-23	260,548	0	754,373	34.5%
2025-07-22	112,746	374	273,432	41.2%
2025-07-21	206,339	971	410,516	50.3%
2025-07-18	339,644	5,155	636,361	53.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE